Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: Insights into the development of Alzheimer's disease

Mild cognitive impairment (MCI) is generally referred to the transitional zone between normal cognitive function and early dementia or clinically probable Alzheimer's disease (AD). Oxidative stress plays a significant role in AD and is increased in the superior/middle temporal gyri of MCI subje...

Full description

Bibliographic Details
Main Authors: D. Allan Butterfield, H. Fai Poon, Daret St. Clair, Jeffery N. Keller, William M. Pierce, Jon B. Klein, William R. Markesbery
Format: Article
Language:English
Published: Elsevier 2006-05-01
Series:Neurobiology of Disease
Online Access:http://www.sciencedirect.com/science/article/pii/S0969996105003025
id doaj-342e87a756104355a1145783e660ef7e
record_format Article
spelling doaj-342e87a756104355a1145783e660ef7e2021-03-20T04:52:13ZengElsevierNeurobiology of Disease1095-953X2006-05-01222223232Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: Insights into the development of Alzheimer's diseaseD. Allan Butterfield0H. Fai Poon1Daret St. Clair2Jeffery N. Keller3William M. Pierce4Jon B. Klein5William R. Markesbery6Department of Chemistry, University of Kentucky, Lexington, KY 40506-0055, USA; Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY 40506, USA; Center of Membrane Sciences, University of Kentucky, Lexington, KY 40506, USA; Corresponding author. Department of Chemistry, Center of Membrane Sciences, and Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY 40506, USA. Fax: +1 859 257 5876.Department of Chemistry, University of Kentucky, Lexington, KY 40506-0055, USAGraduate Center for Toxicology, University of Kentucky, Lexington, KY 40506, USASanders-Brown Center on Aging, University of Kentucky, Lexington, KY 40506, USA; Department of Anatomy and Neurobiology, University of Kentucky, Lexington, KY 40506, USADepartment of Pharmacology and Core Proteomics Laboratory, University of Louisville, Louisville, KY 40208, USAKidney Disease Program and Core Proteomics Laboratory, University of Louisville, Louisville, KY 40208, USASanders-Brown Center on Aging, University of Kentucky, Lexington, KY 40506, USA; Departments of Pathology and Neurology, University of Kentucky, Lexington, KY 40506, USAMild cognitive impairment (MCI) is generally referred to the transitional zone between normal cognitive function and early dementia or clinically probable Alzheimer's disease (AD). Oxidative stress plays a significant role in AD and is increased in the superior/middle temporal gyri of MCI subjects. Because AD involves hippocampal-resident memory dysfunction, we determined protein oxidation and identified the oxidized proteins in the hippocampi of MCI subjects. We found that protein oxidation is significantly increased in the hippocampi of MCI subjects when compared to age- and sex-matched controls. By using redox proteomics, we determined the oxidatively modified proteins in MCI hippocampus to be α-enolase (ENO1), glutamine synthetase (GLUL), pyruvate kinase M2 (PKM2) and peptidyl-prolyl cis/trans isomerase 1 (PIN1). The interacteome of these proteins revealed that these proteins functionally interact with SRC, hypoxia-inducible factor 1, plasminogen (PLG), MYC, tissue plasminogen activator (PLAT) and BCL2L1. Moreover, the interacteome indicates the functional involvement of energy metabolism, synaptic plasticity and mitogenesis/proliferation. Therefore, oxidative inactivation of ENO1, GLUL and PIN1 may alter these cellular processes and lead to the development of AD from MCI. We conclude that protein oxidation plays a significant role in the development of AD from MCI and that the oxidative inactivation of ENO1, GLUL, PKM2 and PIN1 is involved in the progression of AD from MCI. The current study provides a framework for future studies on the development of AD from MCI relevant to oxidative stress.http://www.sciencedirect.com/science/article/pii/S0969996105003025
collection DOAJ
language English
format Article
sources DOAJ
author D. Allan Butterfield
H. Fai Poon
Daret St. Clair
Jeffery N. Keller
William M. Pierce
Jon B. Klein
William R. Markesbery
spellingShingle D. Allan Butterfield
H. Fai Poon
Daret St. Clair
Jeffery N. Keller
William M. Pierce
Jon B. Klein
William R. Markesbery
Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: Insights into the development of Alzheimer's disease
Neurobiology of Disease
author_facet D. Allan Butterfield
H. Fai Poon
Daret St. Clair
Jeffery N. Keller
William M. Pierce
Jon B. Klein
William R. Markesbery
author_sort D. Allan Butterfield
title Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: Insights into the development of Alzheimer's disease
title_short Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: Insights into the development of Alzheimer's disease
title_full Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: Insights into the development of Alzheimer's disease
title_fullStr Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: Insights into the development of Alzheimer's disease
title_full_unstemmed Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: Insights into the development of Alzheimer's disease
title_sort redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of alzheimer's disease
publisher Elsevier
series Neurobiology of Disease
issn 1095-953X
publishDate 2006-05-01
description Mild cognitive impairment (MCI) is generally referred to the transitional zone between normal cognitive function and early dementia or clinically probable Alzheimer's disease (AD). Oxidative stress plays a significant role in AD and is increased in the superior/middle temporal gyri of MCI subjects. Because AD involves hippocampal-resident memory dysfunction, we determined protein oxidation and identified the oxidized proteins in the hippocampi of MCI subjects. We found that protein oxidation is significantly increased in the hippocampi of MCI subjects when compared to age- and sex-matched controls. By using redox proteomics, we determined the oxidatively modified proteins in MCI hippocampus to be α-enolase (ENO1), glutamine synthetase (GLUL), pyruvate kinase M2 (PKM2) and peptidyl-prolyl cis/trans isomerase 1 (PIN1). The interacteome of these proteins revealed that these proteins functionally interact with SRC, hypoxia-inducible factor 1, plasminogen (PLG), MYC, tissue plasminogen activator (PLAT) and BCL2L1. Moreover, the interacteome indicates the functional involvement of energy metabolism, synaptic plasticity and mitogenesis/proliferation. Therefore, oxidative inactivation of ENO1, GLUL and PIN1 may alter these cellular processes and lead to the development of AD from MCI. We conclude that protein oxidation plays a significant role in the development of AD from MCI and that the oxidative inactivation of ENO1, GLUL, PKM2 and PIN1 is involved in the progression of AD from MCI. The current study provides a framework for future studies on the development of AD from MCI relevant to oxidative stress.
url http://www.sciencedirect.com/science/article/pii/S0969996105003025
work_keys_str_mv AT dallanbutterfield redoxproteomicsidentificationofoxidativelymodifiedhippocampalproteinsinmildcognitiveimpairmentinsightsintothedevelopmentofalzheimersdisease
AT hfaipoon redoxproteomicsidentificationofoxidativelymodifiedhippocampalproteinsinmildcognitiveimpairmentinsightsintothedevelopmentofalzheimersdisease
AT daretstclair redoxproteomicsidentificationofoxidativelymodifiedhippocampalproteinsinmildcognitiveimpairmentinsightsintothedevelopmentofalzheimersdisease
AT jefferynkeller redoxproteomicsidentificationofoxidativelymodifiedhippocampalproteinsinmildcognitiveimpairmentinsightsintothedevelopmentofalzheimersdisease
AT williammpierce redoxproteomicsidentificationofoxidativelymodifiedhippocampalproteinsinmildcognitiveimpairmentinsightsintothedevelopmentofalzheimersdisease
AT jonbklein redoxproteomicsidentificationofoxidativelymodifiedhippocampalproteinsinmildcognitiveimpairmentinsightsintothedevelopmentofalzheimersdisease
AT williamrmarkesbery redoxproteomicsidentificationofoxidativelymodifiedhippocampalproteinsinmildcognitiveimpairmentinsightsintothedevelopmentofalzheimersdisease
_version_ 1724211884622610432